Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-Treated With Vasopressin
This study is currently recruiting participants.
Study NCT00635310 Information provided by National Taiwan University Hospital
First Received: March 5, 2008 Last Updated: June 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis C
Chronic Hepatitis B
Biopsy
Hemodialysis
Additional conditions recognized in this trial
Hepatitis
Hepatitis B
Hepatitis B, Chronic
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
DNA Virus Infections
Flaviviridae Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Liver Diseases
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Percutaneous liver biopsy
Additional drug interventions recognized in this trial
Arginine Vasopressin
Deamino Arginine Vasopressin
Vasopressins
More general drug interventions related to this trial
Antidiuretic Agents
Cardiovascular Agents
Coagulants
Hematologic Agents
Hemostatics
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Taiwan University Hospital
National Science Council, Taiwan
Back to top of Main Content
